Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (501-510 of 761) with videos related to

Pageof 77
Sort By:
Circulation|January 2, 2013
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyPayal Kohli, Lars Wallentin, Eric Reyes, et al.
Thrombosis and Haemostasis|December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled studyFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 23, 2013
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trialPilar Jiménez-Quevedo, Lorenzo Hernando, Joan Antoni Gómez-Hospital, et al.
Medicine|March 17, 2023
Adjusted mortality of extracorporeal membrane oxygenation for acute myocardial infarction patients in cardiogenic shockJeong Cheon Choe, Sun-Hack Lee, Jin Hee Ahn, et al.
Journal of the American Heart Association|May 6, 2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> GenotypingLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
Pageof 77

Showing results (501-510 of 761) with videos related to

Sort By:
Pageof 77
Circulation|January 2, 2013
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyPayal Kohli, Lars Wallentin, Eric Reyes, et al.
Thrombosis and Haemostasis|December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled studyFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 23, 2013
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trialPilar Jiménez-Quevedo, Lorenzo Hernando, Joan Antoni Gómez-Hospital, et al.
Medicine|March 17, 2023
Adjusted mortality of extracorporeal membrane oxygenation for acute myocardial infarction patients in cardiogenic shockJeong Cheon Choe, Sun-Hack Lee, Jin Hee Ahn, et al.
Journal of the American Heart Association|May 6, 2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> GenotypingLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
Pageof 77